• Login
  • Blood transport
  • Sitemap
Sarstedt
Tempus 600

  • Our solutions
  • Better treatment
    • One-touch handling
    • Reducing the ToTAT
    • Advantages as a patient
    • Product advantages
    • Facts & advantages
  • References
    • References
    • Case stories
  • Service & Support
  • Clinical publications
  • News
    • News
    • Exhibitions
  • About us
    • Background and ideology behind Tempus600
    • Our vision and mission
    • Our values
    • Jobs
    • Privacy Protection Policy
  • Contact
  • You are here:
  • Frontpage
  • / News
  • / News
  • Back
  • You are here:
  • News

News

DGKL 2014

Monday, September 29, 2014

DGKL in Mannheim, Germany, September 2014, was a great success for Timedico A/S and Tempus600

Again this year Timedico A/S was present at the DGKL congress. The congress took place in Mannheim from 24. – 27. September 2014 and Tempus600 was shown in a 1:1 live version.

Many of the German hospitals came by the booth and had an introduction to Tempus600. Not only was Tempus600 shown at the booth, but The Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, presented a poster in the poster area, where Tempus600 was evaluated using mini data loggers – overwhelming results for Tempus600.

Find the poster here

Apart from visitors from the hospitals, many industrial companies as well as trade magazines came by to hear about Tempus600 and how Tempus600 is about to revolutionize the transport of small clinical samples in hospitals.

Return DGKL 2014; /Default.aspx?ID=1111&newsid=79&Action=1&PID=4787
 
 
 
 
 
 
 
 
 
 
 
 

Menu

  • News
  • Exhibitions

SARSTEDT ApS

Brogesvej 18
DK-7441 Bording
Tel. +45 8686 5762
info.dk@sarstedt.com

Change of cookie consent

Our company is credit worthy according to Bisnode's credit assessment system that is based on a number of decision rules. This credit rating is updated on a daily basis, and always shows the current rating and date.





Your subscription could not be saved. Please try again.
Your subscription has been successful.

Newsletter

Subscribe to our newsletter and stay updated.

Login

Login

Help:Forgot password?